Cardiac & Cardiothoracic

FloraSeal® SurgiSeal® PlasmaBlade™ Aquamantys™ RadiaLux™
  • When compared with non-infectious cardiac device complications, pacemaker infections result in an 8.4x to 11.6x increase in mortality rates along with a mean hospitalisation cost ranging from $31,149 to $55,003.[1]
  • Adding microbial skin sealant results in less contamination of the incision by endogenous skin microbes by the end of the surgical procedure than standard skin prep techniques. There is a subsequent reduction in the risk of Surgical Site Infection (SSI), which is particularly pronounced in obese patients.[2]
FloraSeal®
  • FloraSeal has been shown to trap and immobilise bacteria that may cause infection to the patient. It rapidly and powerfully kills gram-positive and gram-negative bacteria.[3]

1. Fakhro, A., Jalalabadi, F., Brown, R. H., & Izaddoost, S. A. (2016). Treatment of Infected Cardiac Implantable Electronic Devices. Seminars in plastic surgery, 30(2), 60–65.

2. von Eckardstein, A. S., Lim, C. H., Dohmen, P. M., Pêgo-Fernandes, P. M., Cooper, W. A., Oslund, S. G., & Kelley, E. L. (2011). A randomized trial of a skin sealant to reduce the risk of incision contamination in cardiac surgery. The Annals of thoracic surgery, 92(2), 632–637.

3. Prince, D., Kohan, K., Solanki, Z., Mastej, J., Prince, D., Varughese, R., & Patel, M. (2017). Immobilization and death of bacteria by Flora Seal microbial sealant. Int J Pharm Sci Invent, 6(6), 45-49.

SurgiSeal® Topical Skin Adhesive is a high purity, antimicrobial, liquid topical skin adhesive that can replace sutures for incision or laceration repair.

SurgiSeal® is the only topical skin adhesive in the world to receive FDA 510K Clearance in demonstrating inhibition of gram-positive and gram-negative bacteria growth.[1]

SurgiSeal® provides the optimal balance between strength and flexibility. In replacing sutures for incision or laceration repair, it can save time, provide a flexible, water-resistant, protective coating, and eliminate the need for suture removal.

FloraSeal®

1. SurgiSeal IFU: Due to the anhydrous property of the SurgiSeal adhesive, gram+ and gram- bacteria which become incorporated within the adhesive upon application, are not expected to grow.

Cardiac:

  • Reduced risk of thermal damage to transvenous leads[4]
  • Precise dissection with less risk of thermal and mechanical lead damage[4,5,6]
  • Reduced ventricular oversensing or other CIED interactions[4,5]
  • Shown to decrease procedure time by up to 40%, decrease lead damage events, and avoid prolonged hospital stays, resulting in an average cost savings of $155 per case[7]
PlasmaBlade™

PROCEDURES

  • Generator changeouts
  • Generator replacements
  • Generator upgrades
  • Capsulectomy

Cardiothoracic:

  • In thoracic artery harvesting, PlasmaBlade™ demonstrated significantly less endothelial damage than traditional electrosurgery (83% vs 60%)[8]
  • PlasmaBlade™ samples demonstrated a tendency to better wall integrity than traditional electrosurgery (72% vs. 54%)[8]

4. Wilkoff BL, Aurricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs) description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008; 5: 907-925.

4. Wilkoff BL, Aurricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs) description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008; 5: 907-925.
5. Weisberg IL, Desai S, Vose JG, Knight BP. Abstract presented from the podium at Heart Rhythm Society 2010 and Cardiostim 2010.

4. Wilkoff BL, Aurricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiac electronic implantable devices (CIEDs) description of techniques indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008; 5: 907-925.
5. Weisberg IL, Desai S, Vose JG, Knight BP. Abstract presented from the podium at Heart Rhythm Society 2010 and Cardiostim 2010.
6. Kypta A, Blessberger H, Saleh K, Hönig S, Kammler J, Steinwender C. An electrical plasma surgery tool for device replacement--retrospective evaluation of complications and economic evaluation of costs and resource use. PACE 2014; 00:1–7.

7. Vose JG, McAdara-Berkowitz J. Reducing scalpel injuries in the operating room. AORN J. 2009;90(6):867-872.

8. Zientara A, Komminoth P, Seifert B, Odavic D, Dzemali O, Häussler A, Genoni M. Skeletonized internal thoracic artery harvesting: a low thermal damage electrosurgical device provides improved endothelial layer and tendency to better integrity of the vessel wall compared to conventional electrosurgery. J Cardiothorac Surg. 2018;13:105.

Cardiac:

  • Significantly reduced the incidence of haematoma[9]
  • Reduced the need for other haemostatic agents[10]
  • Reduced surgical time[11]
  • Reduced intraoperative blood loss[12]
Aquamantys™

PROCEDURES

  • Generator changeouts
  • Generator replacements
  • Generator upgrades
  • Capsulectomy

Cardiothoracic:

  • Use of the Aquamantys™ during lung resection resulted in reduced transfusion rates compared to traditional electrosurgery (1.8% vs. 14.7%)[13]
  • Significantly less drainage at day 1,2, and 3[13]
  • An average 2.1-day reduction in chest tube permanence time was found when using the Aquamantys™[13]
  • Use of the Aquamantys™ during lung resection resulted in an average of 21.9-minute reduction in operating time compared to traditional electrosurgery[13]
  • Use of the Aquamantys™ during lung resection resulted in an average of 2.2-day reduction in hospital stay compared to traditional electrosurgery[13]

PROCEDURES

  • Decortication
  • Lung resection
  • Mediastinal lymph node dissection
  • Chest wall resection
  • Video Assisted Thoracoscopic Surgery (VATS)

9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

10. Geller DA, Tsung A, Maheshwari V, et al. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB. 2005;7:208-213.

11. Snyder BD, Hedequist D, Shannon E. Bipolar sealing technology to control bleeding in pediatric spine surgery: a retrospective study. Poster presentation at Pediatric OrthopaedicSociety of North America Annual Meeting. 2007;Hollywood, FL.

12. Gordon ZL, Son-Hing JP, Poe-Kochert C, Thompson GH. Bipolar sealer device reduces blood loss and transfusion requirements in posterior spinal fusionfor adolescent idiopathicscoliosis. J Pediatr Orthop. 2013;33(7):700-706.

13. Ibrahim M, Menna C, Maurizi G, et al. Impact of Transcollation technology in thoracic surgery: a retrospective study. Eur J Cardiothorac Surg. 2016;46(2):623–6.

  • The RadiaLux™ lighted retractor is a single-use retractor designed to provide surgeons with the ability to manipulate soft tissue through a combination of blades when assembled onto a retractor handle.
  • The retractor provides illumination to the surgical field independent of an external light source or fibre optic cables.
  • The lighted retractor is indicated for enhancing visibility to a surgical field through retraction of soft tissue and illumination of the surgical cavity.
RadiaLux™

Revolution Surgical Pty Ltd
5/14-16 Crescent Street, Rozelle NSW 2039 AU
ABN: 63 165 643 434

© 2018-2024 Revolution Surgical

Website by: WebInjection